Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children

Authors

Olga Syrkina
Mika Rämet (ORCID: https://orcid.org/0000-0002-5776-164X)
Róbert Simkó (ORCID: https://orcid.org/0000-0002-5475-7725)
Federico Martinón‐Torres (ORCID: https://orcid.org/0000-0002-9023-581X)
Céline Zocchetti
Isabelle Bertrand-Gerentes
Ray F. Ebert
Siham Bchir

Institutions

Tampere University (FI)
Instituto de Salud Carlos III (ES)
Sanofi (France) (FR)
Complejo Hospitalario Universitario de Santiago (ES)
Klinik und Poliklinik für Kinder- und Jugendmedizin (DE)
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
Instituto de Investigación Sanitaria de Santiago (ES)
National Patient Safety Foundation (US)

Publication Details

Journal: Infectious Diseases and Therapy
Published: 2025-04-01
DOI: https://doi.org/10.1007/s40121-025-01121-6
Citations: 7
Primary Topic: Bacterial Infections and Vaccines
Type: article
Field-Weighted Citation Impact: 8.28

Funders

Sanofi

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children

Olga Syrkina, Mika Rämet, Róbert Simkó, Federico Martinón‐Torres et al.

Apr 1, 2025

7 citations

Infectious Diseases and Therapy

Bacterial Infections and Vaccines

8.28

article

Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children

Olga Syrkina, Mika Rämet, Róbert Simkó, Federico Martinón‐Torres, Céline Zocchetti, Isabelle Bertrand-Gerentes, Ray F. Ebert, Siham Bchir

April 1, 2025article en

7 citations

Abstract

No abstract available for this paper.

Infectious Diseases and TherapyVol. 14(5)

Tampere University (FI), Instituto de Salud Carlos III (ES), Sanofi (France) (FR), Complejo Hospitalario Universitario de Santiago (ES), Klinik und Poliklinik für Kinder- und Jugendmedizin (DE), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Instituto de Investigación Sanitaria de Santiago (ES), National Patient Safety Foundation (US)

Sanofi

Good health and well-being

Openalex Percentile: Top 2%

Bacterial Infections and Vaccines

8.28

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children — Olga Syrkina, Mika Rämet, et al. · Infectious Diseases and Therapy (2025) | TGRS Research Map | TGRS